Atrin Pharmaceuticals Overview

  • Founded
  • 2011
  • Status
  • Private
  • Employees
  • 8
  • Latest Deal Type
  • 2ndary - Private
  • Investors
  • 9

Atrin Pharmaceuticals General Information


Developer of anticancer therapeutic drugs designed to treat a broad spectrum of cancers associated with synthetic lethality and the deregulated DNA damage response. The company's drugs are hyperactive in cancer cells, perform a vital function without which the cancer cells could be destroyed and creates a molecule that causes the collapse of replication forks, enabling patients to get new, effective and safe drugs for the treatment of cancer.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Primary Office
  • 3805 Old Easton Road
  • Doylestown, PA 18902
  • United States
+1 (267) 000-0000

Atrin Pharmaceuticals Timeline

Financing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Atrin Pharmaceuticals Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Secondary Transaction - Private 00.000 Completed Pre-Clinical Trials
4. Later Stage VC 01-Oct-2019 00.000 00.000 Completed Pre-Clinical Trials
3. Later Stage VC 15-May-2017 000 000 Completed Pre-Clinical Trials
2. Grant 19-Oct-2016 $300K Completed Pre-Clinical Trials
1. Early Stage VC 22-Apr-2015 Completed Pre-Clinical Trials
To view Atrin Pharmaceuticals’s complete valuation and funding history, request access »

Atrin Pharmaceuticals Executive Team (6)

Name Title Board Seat Contact Info
Oren Gilad Ph.D Co-Founder, President, Chief Executive Officer & Board Member
Richard Fitzgerald Chief Financial Officer
Zeev Weiss Chief Business Officer
You’re viewing 3 of 6 executive team members. Get the full list »

Atrin Pharmaceuticals Board Members (9)

Name Representing Role Since
Bernard Rudnick Self Board Member 000 0000
Jay Rosan Atrin Pharmaceuticals Board Member 000 0000
Jeffrey Dayno MD Self Board Member 000 0000
Marc Duey Self Board Member 000 0000
Michael Grissinger Atrin Pharmaceuticals Board Member 000 0000
You’re viewing 5 of 9 board members. Get the full list »

Atrin Pharmaceuticals Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Atrin Pharmaceuticals Investors (9)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Aljit Joy Angel (individual) Minority 000 0000 000000 0
Bernard Rudnick Angel (individual) Minority 000 0000 000000 0
Duce Management Family Office Minority 000 0000 000000 0
Jason Bell Angel (individual) Minority 000 0000 000000 0
John Oates Angel (individual) Minority 000 0000 000000 0
You’re viewing 5 of 9 investors. Get the full list »